每年全世界约有1000万人患心肌梗死。阿司匹林是通常使用的急诊药物,但英国牛津大学的陈政明(译音)博士及其他科学家发现增加另一种药氯吡格雷(抗血小板聚集药)可防止血液凝结而挽救许多生命。氯吡格雷以商品名Plavix上市,由世界第四大药商赛诺菲-安万特和百时美施贵宝公司经销 About 10 million people worldwide suffer from myocardial infarction each year. Aspirin is commonly used as an emergency medicine, but Dr. Chen Zheng-ming and other scientists at Oxford University in the UK found that adding another drug, clopidogrel (an anti-platelet aggregation drug), prevents blood from clotting and saves many lives. Clopidogrel is marketed under the tradename Plavix and is marketed by Sanofi-Aventis and Bristol-Myers Squibb, the fourth largest drug company in the world